...
首页> 外文期刊>Surgery >Detection of cancer cells in mesenteric vein and peripheral vessels by measuring telomerase activity in patients with colorectal cancer.
【24h】

Detection of cancer cells in mesenteric vein and peripheral vessels by measuring telomerase activity in patients with colorectal cancer.

机译:通过测量结直肠癌患者端粒酶活性来检测肠系膜静脉和外周血管中的癌细胞。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Liver metastasis is an important factor determining prognosis in colorectal cancer. The objective of this study was to assess whether colorectal cancer cells in the drainage veins can be detected by measuring telomerase activity and its detection is correlated with liver metastasis. METHODS: Telomeric repeat amplification protocol assay in combination with an immunomagnetic sorting was used for measuring telomerase activity of epithelial cells in blood samples collected from mesenteric (tumor-drainage) vein and peripheral vessels of 41 colorectal cancer patients. Telomerase activity was calculated as relative telomerase activity (RTA) against a control template and analyzed in terms of liver metastasis. RESULTS: RTA of mesenteric blood samples was significantly higher in patients with liver metastasis (60.8%; n=7) than in those without metastasis (19.7%; n=34; P=.019). The RTA of peripheral blood sample was also higher in patients with liver metastasis (26.8%) than in those without metastasis (11.1%; p=.17). Moreover, 57% of cases with liver metastasis exhibited a positive telomerase activity in mesenteric blood sample, whereas it was 18% in cases without metastasis. CONCLUSIONS: Our assay was proven to be a feasible method for detecting cancer cells in tumor-drainage veins. High telomerase activity of mesenteric blood samples reflected the existence of liver metastasis of colorectal cancer.
机译:背景:肝转移是决定大肠癌预后的重要因素。这项研究的目的是评估是否可以通过测量端粒酶活性来检测引流静脉中的结直肠癌细胞,并且其检测与肝转移有关。方法:采用端粒重复扩增方案测定法和免疫磁分选法,从41例结直肠癌患者的肠系膜(肿瘤引流)静脉和外周血管中采集的血液样本中上皮细胞的端粒酶活性。将端粒酶活性计算为相对于对照模板的相对端粒酶活性(RTA),并根据肝转移进行分析。结果:肝转移患者的肠系膜血样本的RTA显着高于无转移患者的RTA(60.8%; n = 7)(19.7%; n = 34; P = .019)。有肝转移的患者(26.8%)的外周血样本的RTA也高于无转移的患者(11.1%; p = .17)。此外,有57%的肝转移病例在肠系膜血样中表现出端粒酶阳性,而无转移的病例为18%。结论:我们的测定被证明是检测肿瘤引流静脉中癌细胞的一种可行方法。肠系膜血液样本的端粒酶高活性反映了大肠癌肝转移的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号